BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Uchida Y, Inao M, Tsuji S, Uemura H, Kouyama JI, Naiki K, Sugawara K, Nakao M, Nakayama N, Imai Y, Tomiya T, Mochida S. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Hepatol Res 2020;50:1355-64. [PMID: 32886950 DOI: 10.1111/hepr.13566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hosui A, Tanimoto T, Okahara T, Ashida M, Ohnishi K, Wakahara Y, Kusumoto Y, Yamaguchi T, Sueyoshi Y, Hirao M, Yamada T, Hiramatsu N. Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites. J Clin Med 2021;10:294. [PMID: 33466878 DOI: 10.3390/jcm10020294] [Reference Citation Analysis]